Sotagliflozin 200 mg, 40mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg, 40mg
Reference Brands: Inpefa (USA), Zynquista (EU)
Category: Diabetes
Sotagliflozin is an oral dual SGLT-1 and SGLT-2 inhibitor that helps lower blood glucose and reduces the risk of heart-failure related events. It is used in adults with type 2 diabetes and those with heart failure to improve cardiovascular outcomes.
Sotagliflozin — third party manufacturing & bulk supply
Sotagliflozin 200 mg, 40mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Sotagliflozin is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Sotagliflozin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Sotagliflozin →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sotagliflozin is used for improving blood glucose control in adults with type 1 diabetes (as an adjunct to insulin) and type 2 diabetes in some regions. It works by inhibiting both SGLT1 and SGLT2 transporters, reducing glucose absorption in the intestine and increasing glucose excretion through urine.
Sotagliflozin is made from the active ingredient sotagliflozin, a dual sodium–glucose cotransporter inhibitor that blocks SGLT1 in the gut and SGLT2 in the kidneys.
A well-known trade name for Sotagliflozin is Zynquista.
Zynquista was developed by Lexicon Pharmaceuticals in collaboration with Sanofi. In some regions, rights have been managed directly by Lexicon following partnership changes.
The generic name is sotagliflozin.
The brand name is Zynquista.
Sotagliflozin is manufactured in facilities authorized by Lexicon Pharmaceuticals and its regional partners, with production occurring in the United States and Europe depending on regulatory approvals and supply chains.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
